MATINAS BIOPHARMA HOLDINGS, INC.

(MTNB)
  Report
Delayed Nyse  -  05/19 04:00:00 pm EDT
0.6651 USD   +2.24%
05/12TRANSCRIPT : Matinas BioPharma Holdings, Inc., Q1 2022 Earnings Call, May 12, 2022
CI
05/12MATINAS BIOPHARMA HOLDINGS, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
05/12Matinas BioPharma Reports First Quarter 2022 Financial Results and Operational Highlights
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart MATINAS BIOPHARMA HOLDINGS, INC.
Upcoming events on MATINAS BIOPHARMA HOLDINGS, INC.
08/09/22 Interim 2022 Earnings Release (Projected)
11/16/22 Q3 2022 Earnings Release (Projected)
04/04/23 FY 2022 Earnings Release (Projected)
05/16/23 Q1 2023 Earnings Release (Projected)
Past events on MATINAS BIOPHARMA HOLDINGS, INC.
05/12/22 | 08:30am Q1 2022 Earnings Call
05/12/22 Q1 2022 Earnings Release
05/10/22 | 11:00am BioNJ BioPartnering Conference
04/13/22 | 03:00pm Needham Virtual Healthcare Conference
03/28/22 Maxim Group Virtual Growth Conference
03/08/22 | 08:30am FY 2021 Earnings Call
03/08/22 | 06:30am FY 2021 Earnings Release
01/25/22 | 08:30am Business Update Call
11/23/21 | 12:30pm B. Riley Fall Growth Biotech Best Ideas Series Conference
11/15/21 | 02:25pm Piper Sandler Virtual Healthcare Conference - Pre-Recorded
Past dividends on MATINAS BIOPHARMA HOLDINGS, INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
0,15
0,11
43%
0,12
0,16
-25%
0,09
0,11
-21%
0,16
1,12
-86%
0,03
0,36
-91%
 
0,01
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 


 
-18,7
-17,6
-6,3%
-24,0
-24,4
1,7%
-24,5
-24,9
1,6%
 
-25,4
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-16,5
-15,7
-5,3%
-14,6
-13,8
-6,4%
-18,9
-18,3
-3,5%
-24,2
-23,4
-3,4%
-24,7
-25,6
3,3%
 
-30,5
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-15,5
-32,4
52%
-14,1
-13,7
-2,5%
-17,4
-17,3
-0,35%
-22,4
-21,4
-4,9%
-23,3
-24,2
3,9%
 
-28,7
 
Net income
M $
Released
Forecast
Spread
-32,8
-32,4
-1,3%
-15,0
-14,2
-5,8%
-18,3
-17,7
-3,3%
-23,2
-22,0
-5,8%
-23,7
-24,5
3,3%
 
-28,7
 
EPS
$
Released
Forecast
Spread
-0,36
-0,37
2,7%
-0,15
-0,15
-3,4%
-0,13
-0,12
-5,4%
-0,12
-0,12
-4,3%
-0,11
-0,12
8,3%
 
-0,13
 
Announcement Date03/16/201804/01/201903/09/202003/29/202103/08/2022-
Quarterly results
Fiscal Period : December2021 Q12021 Q22021 Q32021 Q42022 Q12022 Q2
Sales
M $
Released
Forecast
Spread
0,03
0,03
33%

0,01
 

1,53
 

0,45
 

0,00
 
 
0,00
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-6,29
-3,80
-66%


 
-6,82
-5,90
-16%
-6,65
-7,10
6,4%

-6,30
 
 
-6,40
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-6,35
-5,67
-12%
-4,79
-5,76
17%
-6,88
-3,76
-83%
-6,71
-7,56
11%
-7,72
-6,71
-15%
 
-7,52
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-4,96
-6,15
19%
-4,79
-5,67
15%
-6,84
-2,94
-132%
-6,70
-7,64
12%
-5,98
-6,99
15%
 
-7,51
 
Net income
M $
Released
Forecast
Spread
-5,17
-6,16
16%
-4,98
-5,68
12%
-6,84
-2,96
-131%
-6,70
-7,64
12%
-5,98
-6,99
15%
 
-7,51
 
EPS
$
Released
Forecast
Spread
-0,03
-0,03
0,00%
-0,02
-0,03
33%
-0,03
-0,02
-33%
-0,03
-0,04
20%
-0,03
-0,03
0,00%
 
-0,03
 
Announcement Date05/10/202108/10/202111/08/202103/08/202205/12/2022-
Previous year Next Year
Upcoming sector events for MATINAS BIOPHARMA HOLDINGS, INC.
More events
Past sector events for MATINAS BIOPHARMA HOLDINGS, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise